Sebastian Ochsenreither

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Paul Nathan, Jessica C. Hassel, Piotr Rutkowski et al. · New England Journal of Medicine · 2021 · 806 citations · Full text

Transferred WT1-Reactive CD8 ⁺ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients

Aude G. Chapuis, Gunnar B. Ragnarsson, Hieu Nguyen et al. · Science Translational Medicine · 2013 · 306 citations

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

Denis Soulières, Sandrine Faivre, Éva Remenár et al. · The Lancet Oncology · 2017 · 214 citations

Placebo-controlled Phase 2, Neoadjuvant Therapy, Medicine +7

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 214 citations

Gortec 2014-01 Tpextreme, Neoadjuvant Therapy, Medicine +11

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Jessica C. Hassel, Sophie Piperno‐Neumann, Piotr Rutkowski et al. · New England Journal of Medicine · 2023 · 213 citations · Full text